Merck & Co., Inc. (NYSE:MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference January 4, 2024 ET Company Participants Peter Dannenbaum – Head, IR Rob Davis – CEO Conference Call Participants Chris Shibutani – Goldman Sachs Chris Shibutani I suspect that people are going to be strolling in, but I don’t like to penalize people who are…
Merck & Co., Inc. (NYSE:MRK) 6th Annual Evercore ISI HealthCONx Conference Transcript November 30, 2023 1:20 PM ET Executives Dr. Eliav Barr – Senior Vice President, Head, Global Clinical Development and CMO Peter Dannenbaum – Vice President, Investor Relations Analysts Umer Raffat – Evercore Umer Raffat Thank you. Listen, thank you guys for being here….
Merck & Co., Inc. (NYSE:MRK) Citi 18th Annual BioPharma Conference September 6, 2023 1:50 PM ET Company Participants Marjorie Green – SVP and Head of Late Stage Oncology, Global Clinical Development Conference Call Participants Andrew Baum – Citi Andrew Baum So delighted to introduce our next speaker, Dr. Marjorie Green at Merck, who heads Oncology…